Shilpa Medicare Ltd 2025 AR2
The report highlights Shilpa Medicare Limited's performance in the fiscal year 2024-25, showcasing a 13% revenue growth to ₹1,30,956 Lakhs and a 35% increase in EBITDA to ₹34,021 Lakhs. The company achieved significant milestones, including the out-licensing of Recombinant Human Albumin to Orion Corporation for European commercialization and receiving CDSCO approval for NorUDCA, India's first-in-class therapy for NAFLD. On the ESG front, the company transitioned to renewable energy, achieving 70% renewable energy consumption and reducing Scope 1 emissions by 22,000 tCO2e per annum through biomass utilization. Additionally, the company maintained its commitment to achieving net-zero greenhouse gas emissions by 2050.
Company: Shilpa Medicare Ltd
Sector: Health Care
Country: India
Year: 2025
Type: AR2
Pages: 298
Shilpa Medicare Ltd
Annual Report
The report highlights Shilpa Medicare Limited's performance in the fiscal year 2024-25, showcasing a 13% revenue growth to ₹1,30,956 Lakhs and a 35% increase in EBITDA to ₹34,021 Lakhs. The company achieved significant milestones, including the out-licensing of Recombinant Human Albumin to Orion Corporation for European commercialization and receiving CDSCO approval for NorUDCA, India's first-in-class therapy for NAFLD. On the ESG front, the company transitioned to renewable energy, achieving 70% renewable energy consumption and reducing Scope 1 emissions by 22,000 tCO2e per annum through biomass utilization. Additionally, the company maintained its commitment to achieving net-zero greenhouse gas emissions by 2050.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2025
Reporting Period
Apr 1, 2024 - Mar 31, 2025
Fiscal Year
2025
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Renewable Energy
Water Consumption
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Net Zero Target
Employees